Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization

Background: Clinicians must closely monitor patients for toxicities after chimeric antigen receptor T-cell therapy (CAR-T). Patient-reported outcomes (PROs) (e.g., toxicities, quality of life) and activity data (e.g., steps, sleep) may complement clinicians’ observations. This study tested the feasi...

Full description

Bibliographic Details
Main Authors: Laura B. Oswald, Xiaoyin Li, Rodrigo Carvajal, Aasha I. Hoogland, Lisa M. Gudenkauf, Doris K. Hansen, Melissa Alsina, Frederick L. Locke, Yvelise Rodriguez, Nathaly Irizarry-Arroyo, Edmondo J. Robinson, Heather S. L. Jim, Brian D. Gonzalez, Kedar Kirtane
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/11/2742